Preemptive lamivudine in hepatitis B patients undergoing chemotherapy.
Del Poggio
Paolo
P
Jamoletti
Carlo
C
Zaccanelli
Maurizio
M
D000970:Antineoplastic Agents / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage*; D008223:Lymphoma / Q000150:complications* / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D055502:Secondary Prevention
D000970:Antineoplastic Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine